New hope for IVF: testing drug to prevent early ovulation
NCT ID NCT07236476
Summary
This study is testing different doses of an experimental medication called LY01021 to help control the timing of ovulation during fertility treatments like IVF. Researchers want to see which dose works best to prevent eggs from releasing too early while being safe for patients. The trial involves about 90 women aged 20-40 who are undergoing fertility procedures and have normal ovarian function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASSISTED REPRODUCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.